| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.2 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.37 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |